A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer
Part of paid clinical trials in Basking Ridge, New Jersey.
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study ID
- NCT06144164
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Breast Cancer
- Breast Carcinoma
- Female Breast Cancer
- Lymphedema
- Lymphedema Arm
- Lymphedema of Upper Arm
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Immediate Lymphatic Reconstruction — PROCEDUREImmediate Lymphatic Reconstruction will happen at the time of Axillary Lymph Node Dissection
- Volumetric arm measurements — DIAGNOSTIC_TESTVolumetric arm measurements will occur at each in-person postoperative visit time points.
- Lymphatic massage — OTHERParticipants will begin self-directed lymphatic massage 24 to 48 h after surgery and will continue to do lymphatic massage 3 times a week for 3 months after surgery or until 3 months after any adjuvant treatments (chemotherapy, radiation, etc.) are completed
- Range of motion exercises — OTHERParticipants will begin self-directed lymphatic massage 24 to 48 h after surgery and will continue to do lymphatic massage 3 times a week for 3 months after surgery or until 3 months after any adjuvant treatments (chemotherapy, radiation, etc.) are completed
- Compression garment use — OTHERParticipants will use compression garments 24 to 48 h after surgery and will continue daily use for at least 8 h a day for 3 months or until 3 months after any adjuvant treatments are completed
Study Details
The purpose of this study to test whether a comprehensive program may help the lymph fluid to drain out of the arm and prevent lymphedema in participants with breast cancer.
Key Dates
- Start date
- Nov 16, 2023
- Status verified
- Nov 2025
- Primary completion
- Mar 16, 2030
- Completion
- Mar 16, 2030
Study Design
- Enrollment
- 285 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- PREVENTION
Arms
- Experimental: Participants with Breast CancerParticipants will have a diagnosis of breast cancer and may undergo axillary lymph node dissection.
Primary Outcome Measure
The difference between the baseline and postoperative arm volume measurement [ Time Frame: Up to 24 months ]
Central Contacts
- Michelle Coriddi, MD646-608-8042
- Babak Mahrara, MD646-608-8085
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) | Basking Ridge | New Jersey | 07920 | Michelle Coriddi, MD 646-608-8042 |
| Memorial Sloan Kettering Monmouth (Limited Protocol Activities) | Middletown | New Jersey | 07748 | Michelle Coriddi, MD 646-608-8042 |
| Memorial Sloan Kettering Bergen (Limited Protocol Activities) | Montvale | New Jersey | 07645 | Michelle Coriddi, MD 646-608-8042 |
| Memorial Sloan Kettering Commack (Limited Protocol Activities) | Commack | New York | 11725 | Michelle Coriddi, MD 646-608-8042 |
| Memorial Sloan Kettering Westchester (Limited Protocol Activities) | Harrison | New York | 10604 | Michelle Coriddi, MD 646-608-8042 |
| Memorial Sloan Kettering Cancer Center (All Protocol Activities) | New York | New York | 10065 | Michelle Coriddi, MD 646-608-8042 |
| Memorial Sloan Kettering Nassau (Limited Protocol Activities) | Uniondale | New York | 11553 | Michelle Coriddi, MD 646-608-8042 |
Find similar trials in Basking Ridge, NJ
By condition
By specialty
By research site
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)· Basking Ridge, NJMemorial Sloan Kettering Monmouth (Limited Protocol Activities)· Middletown, NJMemorial Sloan Kettering Bergen (Limited Protocol Activities)· Montvale, NJMemorial Sloan Kettering Commack (Limited Protocol Activities)· Commack, NYMemorial Sloan Kettering Westchester (Limited Protocol Activities)· Harrison, NYMemorial Sloan Kettering Cancer Center (All Protocol Activities)· New York, NY
Related Studies
- Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA MutationsRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast CancerPHASE2 · Recruiting · Proton Collaborative Group · Scottsdale, Arizona
- Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and LymphomaRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey